X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES FRESENIUS KABI ONCO. ALKEM LABORATORIES/
FRESENIUS KABI ONCO.
 
P/E (TTM) x - 22.1 - View Chart
P/BV x 6.1 3.1 196.5% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 ALKEM LABORATORIES   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
FRESENIUS KABI ONCO.
Mar-13
ALKEM LABORATORIES/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs1,589176 902.8%   
Low Rs1,23279 1,569.4%   
Sales per share (Unadj.) Rs417.537.7 1,107.7%  
Earnings per share (Unadj.) Rs56.35.1 1,105.3%  
Cash flow per share (Unadj.) Rs64.76.7 962.5%  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.942.5 688.5%  
Shares outstanding (eoy) m119.57158.23 75.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.43.4 100.1%   
Avg P/E ratio x25.125.0 100.3%  
P/CF ratio (eoy) x21.818.9 115.2%  
Price / Book Value ratio x4.83.0 161.0%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,65320,135 837.6%   
No. of employees `000NA1.2 0.0%   
Total wages/salary Rs m9,171703 1,304.2%   
Avg. sales/employee Rs ThNM5,176.2-  
Avg. wages/employee Rs ThNM610.4-  
Avg. net profit/employee Rs ThNM699.6-  
INCOME DATA
Net Sales Rs m49,9155,963 837.1%  
Other income Rs m1,64518 9,139.4%   
Total revenues Rs m51,5615,981 862.1%   
Gross profit Rs m8,4821,430 593.1%  
Depreciation Rs m1,006258 390.0%   
Interest Rs m671-26 -2,579.2%   
Profit before tax Rs m8,4511,216 694.9%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m1,606342 469.3%   
Profit after tax Rs m6,731806 835.2%  
Gross profit margin %17.024.0 70.9%  
Effective tax rate %19.028.1 67.5%   
Net profit margin %13.513.5 99.8%  
BALANCE SHEET DATA
Current assets Rs m27,0625,102 530.5%   
Current liabilities Rs m15,3242,385 642.4%   
Net working cap to sales %23.545.6 51.6%  
Current ratio x1.82.1 82.6%  
Inventory Days Days67150 44.3%  
Debtors Days Days41113 36.4%  
Net fixed assets Rs m12,6105,148 244.9%   
Share capital Rs m239158 151.1%   
"Free" reserves Rs m34,4906,556 526.1%   
Net worth Rs m35,0276,732 520.3%   
Long term debt Rs m1,212952 127.2%   
Total assets Rs m54,38710,388 523.6%  
Interest coverage x13.6-45.8 -29.7%   
Debt to equity ratio x00.1 24.5%  
Sales to assets ratio x0.90.6 159.9%   
Return on assets %13.67.5 181.3%  
Return on equity %19.212.0 160.5%  
Return on capital %24.914.6 170.2%  
Exports to sales %12.974.5 17.4%   
Imports to sales %3.124.8 12.5%   
Exports (fob) Rs m6,4614,441 145.5%   
Imports (cif) Rs m1,5401,477 104.3%   
Fx inflow Rs m6,5635,298 123.9%   
Fx outflow Rs m3,0121,772 169.9%   
Net fx Rs m3,5523,525 100.7%   
CASH FLOW
From Operations Rs m7,2591,274 569.7%  
From Investments Rs m1,864-1,204 -154.8%  
From Financial Activity Rs m-9,273-196 4,728.6%  
Net Cashflow Rs m-150-126 118.8%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 33.1 0.3 11,033.3%  
FIIs % 0.0 9.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 9.1 -  
Shareholders   68,381 42,599 160.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  SUN PHARMA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 21, 2017 03:37 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - STRIDES SHASUN LTD COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS